A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease

NCT05923073 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Crohn's Disease

Interventions

DRUG: Guselkumab
DRUG: Guselkumab

Sponsor

Janssen Research & Development, LLC